Literature DB >> 24532673

Practical approach to freezing of gait in Parkinson's disease.

Yasuyuki Okuma.   

Abstract

Freezing of gait in Parkinson's disease and related disorders is common and very disabling. It usually occurs in the advanced stages, although mild forms may develop earlier. Freezing can occur on turning, in narrow spaces, immediately before reaching a destination, and in stressful situations. Dual tasking (motor or cognitive load) aggravates the problem. Freezing of gait in Parkinson's disease usually occurs in the 'off' rather than in the 'on' state. It is, therefore, not entirely drug-resistant; the first step in medical treatment is to ensure adequate dopaminergic stimulation to reduce the 'off' state. There is no good evidence for any specific drug to alleviate freezing. Visual or auditory cues are very helpful as behavioural therapy. Assistive devices, such as a wheeled walker sometimes help. Deep brain stimulation of the subthalamic nucleus may alleviate freezing in the 'off' state. Because of the complexity of freezing, individual patients need a careful assessment-particularly in relation to motor fluctuation-to optimise their treatment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  FREEZING OF GAIT; GAIT ANALYSIS; PARKINSON-S DISEASE; TREATMENT

Mesh:

Year:  2014        PMID: 24532673     DOI: 10.1136/practneurol-2013-000743

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  18 in total

Review 1.  Clinical and methodological challenges for assessing freezing of gait: Future perspectives.

Authors:  Martina Mancini; Bastiaan R Bloem; Fay B Horak; Simon J G Lewis; Alice Nieuwboer; Jorik Nonnekes
Journal:  Mov Disord       Date:  2019-05-02       Impact factor: 10.338

2.  Association of freezing of gait and clinical features in patients with Parkinson's disease.

Authors:  Tülin Aktürk; Hayat Güven; Bülent Güven; Selçuk Çomoğlu
Journal:  Acta Neurol Belg       Date:  2019-10-25       Impact factor: 2.396

3.  Impaired Switching from Self-Prepared Actions in Mild Parkinson Disease.

Authors:  Matthew L Cohen; Nadine A Schwab; Catherine C Price; Kenneth M Heilman
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 4.  Freezing of Gait in Parkinson's Disease: Its Pathophysiology and Pragmatic Approaches to Management.

Authors:  Robert Iansek; Mary Danoudis
Journal:  Mov Disord Clin Pract       Date:  2016-12-26

5.  A patient-invented maneuver to alleviate freezing of gait using a foot loop band.

Authors:  Yasuyuki Okuma
Journal:  Case Rep Neurol       Date:  2014-11-07

6.  Spatiotemporal Characteristics of Freezing of Gait in Patients After Hypoxic-Ischemic Brain Injury: A Pilot Study.

Authors:  Seo Yeon Yoon; Sang Chul Lee; Yong Wook Kim
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

7.  Stimulation in Supplementary Motor Area Versus Motor Cortex for Freezing of Gait in Parkinson's Disease.

Authors:  Sang Jin Kim; Sung Hwa Paeng; Suk Yun Kang
Journal:  J Clin Neurol       Date:  2018-04-27       Impact factor: 3.077

8.  Clinical features of freezing of gait in Parkinson's disease patients.

Authors:  Makoto Sawada; Kenji Wada-Isoe; Ritsuko Hanajima; Kenji Nakashima
Journal:  Brain Behav       Date:  2019-03-09       Impact factor: 2.708

9.  A Comparative Study of Early and Late Onset Freezing of Gait in Parkinson's Disease.

Authors:  Shweta Prasad; Abhishek Lenka; Albert Stezin; Rajini M Naduthota; Menka Jha; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

10.  Long-term Monitoring Gait Analysis Using a Wearable Device in Daily Lives of Patients with Parkinson's Disease: The Efficacy of Selegiline Hydrochloride for Gait Disturbance.

Authors:  Mutsumi Iijima; Hiroshi Mitoma; Shinichiro Uchiyama; Kazuo Kitagawa
Journal:  Front Neurol       Date:  2017-10-24       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.